NCT06099561

Brief Summary

The aim of this project is to evaluate a novel treatment program for individuals with intractable and lethal self-harm. The main questions are: 1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions? The secondary research questions are: 2\. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm? 3\. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions? 4\. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions? 5\. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata? 6\. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
8mo left

Started Sep 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Sep 2023Dec 2026

Study Start

First participant enrolled

September 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 19, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 25, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

3.3 years

First QC Date

October 19, 2023

Last Update Submit

April 28, 2026

Conditions

Keywords

Deliberate self-harmSuicide

Outcome Measures

Primary Outcomes (1)

  • The World Health Organization Disability Assessment Schedule II (WHODAS 2.0)

    Level of daily functioning and disability in the domains of cognition, mobility, self-care, getting along with other people and life activities.

    Monthly from baseline to endpointat 24 months and at follow-up at 36 months.

Secondary Outcomes (3)

  • Five Self-harm behaviour groupings measure (5S-HM)

    Weekly from baseline to endpointat 24 months and at follow-up at 36 months.

  • The 5-level EQ-5D

    Monthly from baseline to endpointat 24 months and at follow-up at 36 months.

  • Cost effectiveness

    Monthly from baseline to endpointat 24 months and at follow-up at 36 months.

Study Arms (1)

Study group

Individuals with current severe, imminent and lethal self-harm with a history of at least two interventions without sufficient reduction of self-harm or suffering.

Behavioral: National specialized medical care unit for severe self-harm behaviour-Consultation model

Interventions

Extensive assessments. Consultation and training for existing treatment providers and caregivers. Network-meetings for providers and caregivers.

Study group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A group of individuals with severe self-harm, commonly with comorbid psychiatric diagnoses and cognitive challanges.

You may qualify if:

  • Having tried or made serious attempt to try at least two different interventions with evidence to reduce self-harm, without sufficient reduction in suffering or self-harm

You may not qualify if:

  • Need for translation services to complete measures or interviews
  • Not able to complete measures or interviews

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Highly Specialized Unit for Self-Harm Behaviours, Skåne

Lund, Skåne County, 22185, Sweden

RECRUITING

MeSH Terms

Conditions

Self-Injurious BehaviorSuicide

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Central Study Contacts

Magnus Nilsson, PhD

CONTACT

Sofie Westling, MD/PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2023

First Posted

October 25, 2023

Study Start

September 1, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations